CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 3, April 2012
180
AFRICA
With Prof Brian Rayner (current president of the Southern
African Hypertension Society) are three stalwarts of the
hypertension community in South Africa, who received
a special award for their dedication to improving
hypertension research and practice in South Africa. From
left to right: Prof Krisela Steyn, Prof Yosuf Variava and
Prof F John Milne.
Colleagues of many years’ standing met at the recent
South African Hypertension Congress. Left: Prof Andries
Brink, editor of
CVJAfrica
and founding president of
the South African Medical Research Council; middle:
Dr Derek Yach, senior vice president of Global Health
and Agriculture Policy, PepsiCo, based in New York;
right: Prof Krisela Steyn, director of the MRC’s Chronic
Diseases of Lifestyle Unit and now a consultant to the
Department of Health, University of Cape Town and other
organisations.
SUBSCRIBE to CVJAfrica & SAJDVD
Fully searchable data set of CVJAfrica (2001-2012) & SAJDVD (2004-2012).
You can subscribe to both these journals online.
– subscription is 200 ZAR for 24/7 access to the CVJAfrica since 2001.
– subscription is 200 ZAR for 24/7 access to the SAJDVD.
Featured in this issue
Volume 9Number1
March 2012
SAJDVD
The SouthAfrican JournalofDIABETES&VASCULARDISEASE
Reviews
Ethics Focus
AchievingBestPractice
DiabetesEducator’s Focus
News
The electronic versionof
the journal is available at
Newantithromboticdrugs
Anticoagulation indiabetic
patients
Gliptins in type2diabetes
Riskof cardiovascular
disease in theBellvillepilot
study
Serum levelsofRAGE and
TNF-
α
in type2diabetes
Serum tumournecrosis
factor-
α
in type2diabetes
Improvingwarfarin control
Liraglutide:an incretin
mimetic
WIN AN IPAD!
Toenter, subscribe toSAJDVDmonthlye-alerts
AFRICA
CardioVascular Journal of Africa (official journal for PASCAR)
JANUARY/FEBRUARY 2012
VOL 23NO 1
AFRICA
SEPTEMBER/OCTOBER 2011
VOL 22NO 5
CardioVascular Journal of Africa (official journal for PASCAR)
CardiovascularJournalofAfrica .Vol 22,No5,September/October 2011
Under-treatment of hypercholesterolaemia
Mutation associated with hypertension
Echocardiographic findings in marfan syndrome
Effect of handgrip training on blood pressure
Cardiovascular risk profiles of untreated hypertensives
Anomalous origin of the left pulmonary artery
Double-chambered right ventricle
Printed byDurbanvilleCommercialPrintersTel:0219464074
Erratum
We regret the drug name Riociguat was wrongly spelt in the article on page 120 of volume 23 number 2. Below is the correct title.
Recruitment of pulmonary hypertension patients for PATENT trial with Riociguat completed
Sub-Saharan pulmonary hypertension study launched
